Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
LBX Pharmacy Chain JSCSHSE:603883 -1.84%80 Gross Margin % is 33.51% as of Mar. 2026, which is 2% above its 10-year median of 32.86. GuruFocus rates SHSE:603883 with a GF Score™ of 80/100 and a GF Value™ of ¥19.22 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 631 Healthcare Providers & Services companies, LBX Pharmacy Chain JSC ranks worse than 62.28% on this metric.
SHSE:603883's Gross Margin % is ranked worse than 62.28% of 631
companies
in the Healthcare Providers & Services industry
Industry Median: 39.96
vs SHSE:603883: 32.13
LBX Pharmacy Chain JSC had a gross margin of 33.51% for the quarter that ended in Mar. 2026 => Competition eroding margins
The 5-Year average Growth Rate of Gross Margin for LBX Pharmacy Chain JSC was 0.40% per year.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
LBX Pharmacy Chain JSC had a gross margin of 33.51% for the quarter that ended in Mar. 2026 => Competition eroding margins
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
LBX Pharmacy Chain JSC Gross Margin % Related Terms
LBX Pharmacy Chain JSC Gross Margin % Historical Data
* Premium members only.
The historical data trend for LBX Pharmacy Chain JSC's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, LBX Pharmacy Chain JSC's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
LBX Pharmacy Chain JSC Gross Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, LBX Pharmacy Chain JSC's Gross Margin % distribution charts can be found below:
* The bar in red indicates where LBX Pharmacy Chain JSC's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
LBX Pharmacy Chain JSC (SHSE:603883) has a Gross Margin % of 33.51% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on LBX Pharmacy Chain JSC and its competitors. This is near median its historical median of 32.86. Over the past decade, LBX Pharmacy Chain JSC's Gross Margin % has ranged from 31.88 to 36.06. According to the industry distribution chart, LBX Pharmacy Chain JSC ranks #393 out of 631 companies in the Healthcare Providers & Services industry, placing it in the top 62.3%.
Is LBX Pharmacy Chain JSC's Gross Margin % too high?
LBX Pharmacy Chain JSC's current Gross Margin % of 33.51% is near median its 10-year median of 32.86. Over the past 10 years, this metric has ranged from a low of 31.88 to a high of 36.06. The Healthcare Providers & Services industry median Gross Margin % is 39.96. LBX Pharmacy Chain JSC's value of 33.51% is 16.1% below this industry median. Based on the distribution chart, LBX Pharmacy Chain JSC ranks #393 out of 631 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, LBX Pharmacy Chain JSC has a GF Score™ of 80/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does LBX Pharmacy Chain JSC's Gross Margin % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, LBX Pharmacy Chain JSC ranks #393 out of 631 companies for Gross Margin %. This places LBX Pharmacy Chain JSC in the lower half of its industry. The industry median Gross Margin % is 39.96. LBX Pharmacy Chain JSC's value of 33.51% is 16.1% below this benchmark. Historically, LBX Pharmacy Chain JSC's own Gross Margin % has ranged from 31.88 to 36.06 over the past decade. While the company's 10-year median is 32.86 vs. the industry median of 39.96, LBX Pharmacy Chain JSC has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Healthcare Providers & Services company?
The median Gross Margin % among Healthcare Providers & Services companies is 39.96, based on 631 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. LBX Pharmacy Chain JSC's current Gross Margin % of 33.51% is 16.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on LBX Pharmacy Chain JSC and its competitors. For the Healthcare Providers & Services industry, the median Gross Margin % is 39.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. LBX Pharmacy Chain JSC's current Gross Margin % is 33.51%, which is near median its own 10-year median of 32.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LBX Pharmacy Chain JSC stock overvalued right now?
Based on GuruFocus' analysis, LBX Pharmacy Chain JSC (SHSE:603883) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥19.22, compared to a current price of ¥12.27 — trading 36.2% below its estimated fair value. The current Gross Margin % is 33.51%, which is near median its 10-year median of 32.86 and 16.1% below the Healthcare Providers & Services industry median of 39.96. LBX Pharmacy Chain JSC's overall GF Score™ is 80/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For LBX Pharmacy Chain JSC (SHSE:603883), the current Gross Margin % is 33.51% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is LBX Pharmacy Chain JSC (SHSE:603883) Overvalued in 2026?
Based on GuruFocus' analysis, LBX Pharmacy Chain JSC stock appears to be undervalued.
The current stock price of ¥12.27 is trading 36.2% below its estimated GF Value™ of ¥19.22.
GuruFocus considers LBX Pharmacy Chain JSC to be Significantly Undervalued.
Key valuation signals for SHSE:603883:
Gross Margin %: 33.51% (near median its 10-year median of 32.86)
GF Value™: ¥19.22 vs. price of ¥12.27 (36.2% below fair value)
Industry Position: 16.1% below the Healthcare Providers & Services median (#393 of 631)
No single metric tells the full story. See the SHSE:603883 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
LBX Pharmacy Chain JSC is a China-based company engages in the sale of medicine and health products. The company is engaged in retailing drugs and other related products, including Chinese and Western medicine, prepared slices of Chinese crude drugs, health equipment, healthy food, and personal care products and life care products. The company is also involved in the wholesale and manufacture of drugs.
80GF Score
Get the complete analysis for SHSE:603883
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603883 has been successfully added to your 
